IFLR1000

Magenta Therapeutics NASDAQ IPO

20/6/2018
IPO
Select tab

Announced

20/6/2018

Overview:

  • Magenta Therapeutics has raised $100 million with its IPO on NASDAQ.
  • JPMorgan Chase, Goldman Sachs and Cowen acted as underwriters.

Mihail Georgiev - Data analyst

Jurisdictions:

United States
New York

Deal type:

IPO

Practice area:

Capital markets : Equity

Governing laws:

New York
United States

Industry sector:

Pharmaceuticals and life sciences

Firm:
Goodwin Procter

Party: Magenta Therapeutics Inc (Issuer)

Lawyers: Joseph Theis Jr, Stuart Cable

Related deals